With nine manufacturing plants and 4000 employees in India and abroad, Wockhardt achieves its growth and profitability through quality products and services, increasing investment in R&D, thrust on global markets and its competent scientific and managerial manpower.

Wockhardt draws its global competitive advantage from its strengths in the domestic market. Ranked fifth in India Wockhardt today, has leadership status in therapeutic segments such as pain and inflammation, anti-infectives, anti-depressants, cardio-vasculars, antihypertensives, corticosteriods, cough syrups, etc. International marketing through acquisitions and joint ventures is one of the major thrust areas at Wockhardt. Wockhardt is among the world’s leading producers of bulk drugs

The short to medium term strategy of Wockhardt’s R&D programme is ‘Focus on Technology’, while its long term strategy is oriented to ‘Innovation’. 

Wockhardt’s vision of becoming ‘the most admired pharmaceutical and healthcare company in India’ within the next 10 years is based on a strategy of widening customer reach and creating mega brands through stronger customer relations. 

We at TCI strongly believe that widening customer reach means reaching at the right place, at the right time. Our association with Wockhardt runs over many years and has grown stronger with time.